Ipsilateral Malignant Axillary Lymphadenopathy and Contralateral Reactive Lymph Nodes in a COVID-19 Vaccine Recipient With Breast Cancer
Adin ME, Wu J, Isufi E, Tsui E, Pucar D. Ipsilateral Malignant Axillary Lymphadenopathy and Contralateral Reactive Lymph Nodes in a COVID-19 Vaccine Recipient With Breast Cancer. Journal Of Breast Cancer 2022, 25: 140-144. PMID: 35380021, PMCID: PMC9065355, DOI: 10.4048/jbc.2022.25.e12.Peer-Reviewed Case Reports and Technical NotesLymph nodesNodal enlargementAxillary lymphadenopathyMRNA coronavirus disease 2019 (COVID-19) vaccinesBilateral axillary lymph nodesCOVID-19 vaccine recipientsRight-sided lymph nodesMRNA COVID-19 vaccinationCoronavirus disease 2019 (COVID-19) vaccinesIpsilateral axillary lymphadenopathyMalignant axillary lymphadenopathyAxillary lymph nodesPre-menopausal femalesRight breast lumpBreast cancer patientsCommon benign conditionReactive lymph nodesCOVID-19 vaccinationPotential disease progressionMagnetic resonance imagingVaccine recipientsSecond doseContralateral nodesCortical thickeningBreast lump